VERU INC. Other Tax Expense (Benefit)
VERU INC. (VERU) reported Other Tax Expense (Benefit) of $233.00 thousand for the 12-month period ending 2012-09-30, per its 10-K filed 2014-12-02.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherTaxExpenseBenefit · last filed 2014-12-02
- VERU INC. other tax expense (benefit) for fiscal 2012 was $233.00K, a 73.88% increase from fiscal 2011.
- VERU INC. other tax expense (benefit) for fiscal 2011 was $134.00K.
| Period end | Other Tax Expense (Benefit) 12 month |
|---|---|
| 2012-09-30 | $233.00K 10-K · filed 2014-12-02 |
| 2011-09-30 | $134.00K 10-K · filed 2013-12-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |